search
chemotherapy
Trends
- 1Pancreatic cancer drug cuts death risk by 60% in trial▼A pancreatic cancer drug cut the risk of death by 60% versus chemotherapy in a trial.
A new pancreatic cancer drug reduced the risk of death by 60% compared with standard chemotherapy in a clinical trial, a major result for one of the hardest-to-treat cancers. Pancreatic cancer has among the lowest survival rates, so any substantial improvement over chemotherapy draws wide attention from patients, doctors and researchers.
- 2ELN Systems Shape AML Risk Stratification and Fitness Assessment▼AML Risk Stratification and Fitness Assessment: ELN Systems and Objective Criteria
Discussion is focusing on how European LeukemiaNet (ELN) recommendations are used to stratify risk in acute myeloid leukemia (AML) and to assess patient fitness before treatment. The framework relies on objective genetic and clinical criteria to guide whether patients receive intensive chemotherapy or lower-intensity approaches. Clinicians point to it as a key standard for treatment decisions.
- 3Immunotherapy Offers New Hope in Oral Cavity Cancer Treatment▼Immune Checkpoint Blockers and Engineered Cells Reshape the Fight Against Oral Cavity Cancer
Immune checkpoint inhibitors and engineered cell therapies are changing how doctors treat oral cavity cancer, a disease long managed mainly with surgery, radiation and chemotherapy. Reports highlight how these immunotherapies help the immune system recognize and attack tumors, offering options for patients with advanced or hard-to-treat cases and prompting discussion among oncologists and patients about access and effectiveness.